DGIdb - PALIVIZUMAB Drug Record

PALIVIZUMAB chembl:CHEMBL1201586 Approved

Alternate Names:

MEDI-493
SYNAGIS ABBOSYNAGIS
SYNAGIS
PALIVIZUMAB
ANTI-RSV
chembl:CHEMBL1201586
chemidplus:188039-54-5
rxcui:194279
drugbank:00110

Drug Info:

Drug Categories	specific immunoglobulins
Drug Categories	immunoglobulins
Drug Categories	immune sera and immunoglobulins
Drug Categories	antiinfectives for systemic use
Drug Categories	fusion protein inhibitors
Drug Categories	respiratory syncytial virus anti-f protein monoclonal antibody

(0 More Sources)

Publications:

Overington et al., 2006, How many drug targets are there?, Nat Rev Drug Discov
Imming et al., 2006, Drugs, their targets and the nature and number of drug targets., Nat Rev Drug Discov
Hiatt A et al., 2014, Glycan variants of a respiratory syncytial virus antibody with enhanced effector function and in vivo efficacy., Proc Natl Acad Sci U S A

PALIVIZUMAB C1QA

Interaction Score: 5.68

Interaction Types & Directionality:

n/a

Interaction Info:

PMIDs:
17139284 17016423 24711420

Sources:
DrugBank
PALIVIZUMAB C1R

Interaction Score: 5.68

Interaction Types & Directionality:

n/a

Interaction Info:

PMIDs:
17139284 17016423 24711420

Sources:
DrugBank
PALIVIZUMAB C1QB

Interaction Score: 4.73

Interaction Types & Directionality:

n/a

Interaction Info:

PMIDs:
17139284 17016423 24711420

Sources:
DrugBank
PALIVIZUMAB C1QC

Interaction Score: 4.06

Interaction Types & Directionality:

n/a

Interaction Info:

PMIDs:
17139284 17016423 24711420

Sources:
DrugBank
PALIVIZUMAB FCGR2B

Interaction Score: 2.37

Interaction Types & Directionality:

n/a

Interaction Info:

PMIDs:
17139284 17016423 24711420

Sources:
DrugBank
PALIVIZUMAB FCGR1A

Interaction Score: 2.18

Interaction Types & Directionality:

n/a

Interaction Info:

PMIDs:
17139284 17016423 24711420

Sources:
DrugBank
PALIVIZUMAB FCGR3B

Interaction Score: 0.98

Interaction Types & Directionality:

n/a

Interaction Info:

PMIDs:
17139284 17016423 24711420

Sources:
DrugBank
PALIVIZUMAB FCGR3A

Interaction Score: 0.89

Interaction Types & Directionality:

n/a

Interaction Info:

PMIDs:
17139284 17016423 24711420

Sources:
DrugBank

DrugBank: DB00110
- Version: 5.1.7
Alternate Names:

PALIVIZUMAB DrugBank Drug Name

188039-54-5 CAS Number

Synagis Drug Brand

Drug Info:

Drug Type biotech

Drug Groups approved

Drug Groups investigational

Publications:

Hiatt A et al., 2014, Glycan variants of a respiratory syncytial virus antibody with enhanced effector function and in vivo efficacy., Proc Natl Acad Sci U S A
TTD: Palivizumab
- Version: 2020.06.01
Alternate Names:

D0A1AS TTD Drug ID

Drug Info:

Publications:
ChemblDrugs: chembl:CHEMBL1201586
- Version: ChEMBL_27
Alternate Names:

Drug Info:

Publications:

PALIVIZUMAB	DrugBank Drug Name
188039-54-5	CAS Number
Synagis	Drug Brand

Drug Type	biotech
Drug Groups	approved
Drug Groups	investigational

PALIVIZUMAB Drug Record

PALIVIZUMAB chembl:CHEMBL1201586 Approved

Alternate Names:

Drug Info:

Publications:

Interaction Types & Directionality: n/a

Interaction Info:

PMIDs: 17139284 17016423 24711420

Sources: DrugBank

Interaction Types & Directionality: n/a

Interaction Info:

PMIDs: 17139284 17016423 24711420

Sources: DrugBank

Interaction Types & Directionality: n/a

Interaction Info:

PMIDs: 17139284 17016423 24711420

Sources: DrugBank

Interaction Types & Directionality: n/a

Interaction Info:

PMIDs: 17139284 17016423 24711420

Sources: DrugBank

Interaction Types & Directionality: n/a

Interaction Info:

PMIDs: 17139284 17016423 24711420

Sources: DrugBank

Interaction Types & Directionality: n/a

Interaction Info:

PMIDs: 17139284 17016423 24711420

Sources: DrugBank

Interaction Types & Directionality: n/a

Interaction Info:

PMIDs: 17139284 17016423 24711420

Sources: DrugBank

Interaction Types & Directionality: n/a

Interaction Info:

PMIDs: 17139284 17016423 24711420

Sources: DrugBank

DrugBank: DB00110

Alternate Names: PALIVIZUMAB DrugBank Drug Name 188039-54-5 CAS Number Synagis Drug Brand

Drug Info: Drug Type biotech Drug Groups approved Drug Groups investigational

Publications: Hiatt A et al., 2014, Glycan variants of a respiratory syncytial virus antibody with enhanced effector function and in vivo efficacy., Proc Natl Acad Sci U S A

TTD: Palivizumab

Alternate Names: D0A1AS TTD Drug ID

Drug Info:

Publications:

ChemblDrugs: chembl:CHEMBL1201586

Alternate Names:

Drug Info:

Publications:

Interaction Types & Directionality:

n/a

PMIDs:
17139284 17016423 24711420

Sources:
DrugBank

Interaction Types & Directionality:

n/a

PMIDs:
17139284 17016423 24711420

Sources:
DrugBank

Interaction Types & Directionality:

n/a

PMIDs:
17139284 17016423 24711420

Sources:
DrugBank

Interaction Types & Directionality:

n/a

PMIDs:
17139284 17016423 24711420

Sources:
DrugBank

Interaction Types & Directionality:

n/a

PMIDs:
17139284 17016423 24711420

Sources:
DrugBank

Interaction Types & Directionality:

n/a

PMIDs:
17139284 17016423 24711420

Sources:
DrugBank

Interaction Types & Directionality:

n/a

PMIDs:
17139284 17016423 24711420

Sources:
DrugBank

Interaction Types & Directionality:

n/a

PMIDs:
17139284 17016423 24711420

Sources:
DrugBank

Alternate Names:

PALIVIZUMAB DrugBank Drug Name

188039-54-5 CAS Number

Synagis Drug Brand

Drug Info:

Drug Type biotech

Drug Groups approved

Drug Groups investigational

Publications:

Hiatt A et al., 2014, Glycan variants of a respiratory syncytial virus antibody with enhanced effector function and in vivo efficacy., Proc Natl Acad Sci U S A

Alternate Names:

D0A1AS TTD Drug ID